OUTLINE
In order to avoid platelet activation all
manipulations
must be performed as quickly and as acurate as possible.Work on ice if
possible!
This protocol is based on
differential centrifugation
that allows to
separate platelets from blood cells. Also you can use Robinson
procedure (consult the HANDBOOK OF FLOW CYTOMETRY METHODS)
PROTOCOL
- Bleed animals via the plexus retroorbitalis or the
tail vein under ether anesthesia
- Collect blood into 1,5 eppendorf tubes with ACD
(acid-citrate-dextrose; Sigma C-3821) = 1 vol of ACD : 3 vol of blood :
6.6 vol of NaN 3 0,05%-PBS
- Cetrifuge at 216-220g , 5-7min , 10ƒC
- Take & save at 4ƒC PRP (platelet-rich plasma
)
- Add 1ml of either NaN3
0,05%-PBS or BSGC to the remainig eythrocytes and other cells
- Cetrifuge at 216-220g , 5-7min , 10ƒC
- Take & save at 4ƒC PRP (platelet-rich plasma )
- Add 1ml of either NaN3
0,05%-PBS or BSGC to the remainig eythrocytes and other cells
- Cetrifuge at 216-220g , 5-7min , 10ƒC
- Take & save at 4ƒC PRP (platelet-rich plasma )
- Pool saved PRP
- Cetrifuge at 1613g , 10min , 10ƒC
- Aspirate supernatant (SN)
- Resuspend sedimented platelets in either EDTA 1%-NaCl
0.9% or BSGC
- Cetrifuge at 216-220g , 5-7min , 10ƒC
- Resuspend in in either EDTA 1%-NaCl 0.9% or BSGC.
Count platelets
- Transfer SN into another tube, save at 4ƒC
SOLUTIONS
- ACD = 0.1 mol/L trisodium citrate, 0.11
mol/L dextrose, and 71 mmol/L citric acid monohydrate
- ACD pH 4.9 =
trisodium citrate dihydrate 22g/L
+ citric acid monohydrate 8g/L + dextrose 24.5 g/L
- NaN3
0.05%-PBS (for 500ml) =
100ml PBS(x 5) + 400ml ddH2O + 0.25g NaN 3 pH7.0-7.2
- PBS (x5)(phosphate buffer
saline x5) (for 5L) = 180g
NaCl +
37g Na 2HPO4*2H
2O + 10.75g KH2PO4 + ddHO
to 5L
- EDTA 1%-NaCl 0.9% (for 500ml)= 5g EDTA + 0.9% NaCl to
500ml pH 7.0
- BSGC = 8.6 mM Na2HPO4, 1.6 mM
KH2PO4, 0.12 M NaCl, 0.9 mM EDTA, 13.6 mM Na citrate, 11.1 mM glucose,
pH 7.3 (Levin et al, 1999)
ADDITIONAL INFO
- it's possible to bleed mice by cardiac puncture under
ether anesthesia.
- it's possible to collect blood into sodium
citrate 3.8% ( 0.1 mol/L ) = 1 vol citrate : 9 vol blood : 50 vol
buffered saline-glucose-citrate pH7.3 // or heparin 7.5 U/ml
- RCF = 1.12 x r x (RPM/100) x
(RPM/100) where RCF-relative centrifugal force in g , r -centrifuge radius in mm , RPM-rotations
per min in rpm
- To avoid contamination of PRP with leukocytes and
erythrocytes take PRP-upper&middle layers
SCHEME

[ enlarge
]
REFERENCES
- Semple, J.W., Speck, E.R., Cosgrave, D., Lazarus,
A.H., Blanchette, V.S. and Freedman, J. (1999). Extreme
leukoreduction of major histocompatibility complex class II positive B
cells enhances allogeneic platelet immunity. Blood 93(2): 713-20.
- Jin, J., Quinton, T.M., Zhang, J., Rittenhouse, S.E.
and Kunapuli, S.P. (2002). Adenosine
diphosphate (ADP)-induced thromboxane A(2) generation in human
platelets requires coordinated signaling through integrin
alpha(IIb)beta(3) and ADP receptors. Blood 99(1): 193-8.
- Khetawat, G., Faraday, N., Nealen, M.L., Vijayan,
K.V., Bolton, E., Noga, S.J. and Bray, P.F. (2000). Human
megakaryocytes and platelets contain the estrogen receptor beta and
androgen receptor (AR): testosterone regulates AR expression. Blood
95(7): 2289-96.
|
|